Human immunodeficiency virus type 1 (HIV-1)- and Epstein-Barr virus- specific cytotoxic T lymphocyte precursors exhibit different kinetics in HIV- 1-infected persons

29Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

The frequencies of human immunodeficiency virus type 1 (HIV-1) Gag- and Epstein-Barr virus (EBV)-specific cytotoxic T lymphocyte precursors (CTLp) were studied longitudinally in peripheral blood mononuclear cells from 9 HIV- 1-infected persons. By antigen-specific stimulation, HIV-1 Gag-specific CTLp were detected in vitro throughout the coarse of HIV-1 infection, even after the onset of overt disease. In 4 patients, however, HIV-1 Gag-specific CTLp frequencies declined over time in the presence of maintained EBV-specific CTLp. This decline was correlated with decreasing CD4 (r = .38; P < .05) and CDg (r = .75; P < .001) cell numbers. The maintenance of EBV-specific CTLp in patients with low CD4 cell numbers indicated that EBV-specific CTL-mediated immunity may remain longer unaffected by HIV-1-induced immune dysfunction. Consistent with this observation, the growth of EBV-specific CTL could be supported in vitro by EBV-infected lymphoblastoid B cell lines, independent of both CD4 cells and exogenous cytokines.

Cite

CITATION STYLE

APA

Geretti, A. M., Dings, M. E. M., Van Els, C. A. C. M., Van Baalen, C. A., Wijnholds, F. J., Borleffs, J. C. C., & Osterhaus, A. D. M. E. (1996). Human immunodeficiency virus type 1 (HIV-1)- and Epstein-Barr virus- specific cytotoxic T lymphocyte precursors exhibit different kinetics in HIV- 1-infected persons. Journal of Infectious Diseases, 174(1), 34–45. https://doi.org/10.1093/infdis/174.1.34

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free